Healthcare (Prescription Drugs)

passed · Michigan · Senate Mar 6, 2025

SB 94: Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0095'25

SB 94 prohibits drug manufacturers, wholesalers, and distributors from restricting 340B program pharmacies from accessing or receiving 340B drugs, which are discounted medications for safety-net healthcare providers. It requires 340B entities (like community health centers) to submit annual compliance reports starting in 2026, including program audits and community impact details. Additionally, drug manufacturers must report price increases exceeding 15% for drugs costing over $40 per treatment course, including cost data and patent details. These provisions directly affect pharmaceutical companies, participating pharmacies, and healthcare providers enrolled in the federal 340B drug pricing program.

Topics ✓ HealthcareSupports HealthcareProhibits drug manufacturers from restricting 340B pharmacy access to discounted medications, strengthening safety-net provider access to affordable drugs and improving patient access to essential medications.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · Michigan · Senate Sep 17, 2025

SB 552: Insurance: health insurers; coverage for a nonopioid analgesic drug for pain treatment; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406ll.

SB 552 requires Michigan health insurers to cover non-opioid pain medications prescribed for pain treatment, directly affecting insurers and policyholders. The bill mandates that insurers include such drugs on preferred drug lists within 90 days of FDA approval, prohibits discouraging coverage relative to opioids (e.g., labeling non-opioid drugs as "nonpreferred" when opioids are preferred), and prevents overly restrictive prior authorization for non-opioid options. It does not require insurers to cover specific drugs but ensures equal treatment compared to opioid alternatives in formularies. The law applies to all health insurance policies covering prescription drugs in Michigan.

Topics ✓ HealthcareSupports HealthcareMandates insurer coverage of non-opioid pain meds, prohibits discouraging alternatives to opioids, improving patient access to safer pain management options.95% confidence

Sub-Topics Insurance Prescription Drugs Substance Abuse

Track

passed · Michigan · House Jan 28, 2026

HB 4878: Health: pharmaceuticals; reporting certain information and regulating certain conduct related to drugs and the federal 340B program; provide for. Creates new act.

HB 4878 regulates Michigan's participation in the federal 340B drug pricing program, which allows qualifying hospitals to purchase drugs at discounted prices. The bill requires drug manufacturers to report annual price increases exceeding 15% for drugs costing over $40 per treatment course (Sec. 7), and mandates hospitals using 340B discounts to spend savings on patient services or community health programs (Sec. 11). Hospitals must also report detailed financial data about 340B drug transactions to the state by November 2026 (Sec. 15). These provisions directly affect drug manufacturers, hospitals, and pharmacies participating in the 340B program, aiming to increase transparency and ensure discounts benefit patient care.

Topics ✓ HealthcareSupports HealthcareMandates hospitals using 340B discounts to spend savings on patient services/community programs (Sec. 11), directly advancing patient access and healthcare funding.95% confidence

Sub-Topics Prescription Drugs

Track

passed · Michigan · Senate Jul 1, 2025

SB 397: Human services: medical services; exemption of certain prescription drugs from the medical assistance prior authorization process; provide for. Amends sec. 109h of 1939 PA 280 (MCL 400.109h).

SB 397 removes the prior authorization requirement for specific prescription drugs under Michigan's medical assistance program (Medicaid). This directly affects Medicaid beneficiaries and healthcare providers by allowing immediate coverage for designated drugs without waiting for insurer approval. The bill amends state law to automatically cover these medications, eliminating a step that previously delayed access. It applies only to drugs explicitly named in the legislation, streamlining treatment for covered conditions.

Topics ✓ HealthcareSupports HealthcareRemoves prior authorization barriers for Medicaid prescription drugs, improving immediate patient access to covered medications.95% confidence

Sub-Topics Medicaid Prescription Drugs

Track

passed · Michigan · Senate Jul 1, 2025

SB 403: Health occupations: pharmacists; dispensing certain addiction medications without undue delay; require. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 7333c.

SB 403 requires Michigan pharmacists to dispense certain medications used to treat addiction without unnecessary delay. This directly affects pharmacists who handle these medications and patients seeking treatment for substance use disorders. The bill amends Michigan's Pharmacy Act (MCL 333.1101 et seq.) by adding a new provision that eliminates administrative barriers causing delays in providing these critical medications. It establishes a clear requirement for prompt dispensing while maintaining pharmacists' existing professional responsibilities.

Topics ✓ HealthcareSupports HealthcareRequires pharmacists to dispense addiction medications without undue delay, directly improving patient access to substance use disorder treatment per bill's explicit mandate.95% confidence

Sub-Topics Prescription Drugs Substance Abuse

Track

in committee · Michigan · House Oct 23, 2025

HB 5108: Health occupations: pharmacists; pharmacist scope of practice; modify. Amends secs. 5111, 17703, 17707, 17708, 17724a, 17744, 17744a, 17751, 17757 & 17763 of 1978 PA 368 (MCL 333.5111 et seq.) & adds sec. 17744h.

HB 5108 modifies Michigan's Public Health Code to expand pharmacists' scope of practice. It adds Section 17744h, allowing pharmacists to prescribe certain medications for minor conditions like strep throat or urinary tract infections without a doctor's referral. The bill also updates existing sections (including 17703, 17707, and 17751) to align with these new prescribing authorities. This directly affects community pharmacists and patients seeking convenient, timely care for common, non-emergency conditions. The changes aim to improve access to basic healthcare services within pharmacy settings.

Topics ✓ HealthcareSupports HealthcareExpands pharmacist prescribing authority for minor conditions, improving patient access to timely care without physician referral, directly enhancing healthcare accessibility.95% confidence

Sub-Topics Healthcare Workforce Medical Licensing Prescription Drugs

Track

in committee · Michigan · House Nov 5, 2025

HB 5204: Insurance: health insurers; prescription drug coverage for metastatic cancer; prohibit certain conditions. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406rr.

HB 5204 requires health insurers in Michigan to cover prescription drugs for advanced metastatic cancer without first forcing patients to fail other treatments or prove prior drug failures. It directly affects patients diagnosed with advanced metastatic cancer (cancer that has spread beyond its original site) and their health insurance plans. The law prohibits insurers from imposing conditions like "fail first" requirements or demanding proof of previous drug ineffectiveness before approving coverage for these drugs or related symptoms. This applies to all health insurance policies covering prescription drugs for such cancer cases. The bill defines "advanced metastatic cancer" and "associated conditions" (symptoms or side effects worsening without treatment) to clarify coverage requirements.

Topics ✓ HealthcareSupports HealthcareProhibits 'fail first' requirements for metastatic cancer drug coverage, ensuring timely access without prior treatment failures, directly expanding patient access to essential care.95% confidence

Sub-Topics Prescription Drugs

Track